Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Angitia Biopharmaceuticals | Westlake Village | Series D | $130.0M | 2026-02-05 |
| Mogulinker Technology | Shenzhen | Series C | $14.9M | 2026-09-03 |
| Listenai | Hefei | Series B | $73.7M | 2026-07-10 |
| TuringQ | Shanghai | Series B | $13.9M | 2026-04-27 |
| EAVISION | Suzhou | Series D | $11.8M | 2025-04-01 |
| Neurodome | Xian Shi | Series A | $14.5M | 2026-03-12 |
| CureGenetics | Suzhou | Series B | $9.0M | 2024-03-28 |
| Atom Bioscience & Pharmaceutical | Suzhou | Series D | $82.1M | 2023-10-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 41 Oriza Holdings portfolio companies have raised $758.6M in total.
- 7 of them closed their most recent round in the last 12 months, $261.2M combined.
- The largest of those rounds is Angitia Biopharmaceuticals' $130.0M Series D, dated February 2026.
- The most recent is Mogulinker Technology's $14.9M Series C on 3 September 2026.
- Qiming Venture Partners is an investor in 3 of them, more than any other fund.
- Software is the most common sector, with 23 companies (56%).
- 15% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
15 of 41| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Mogulinker Technology | Mogulinker Technology supplies SaaS software for the post-industrial equipment market. | Artificial intelligence | Shenzhen, China | Series C | $14.9M | 2026-09-03 | $32.4M | GGV Capital, Yinxinggu Capital, Oriza Holdings +1 | 51 to 100 | 2016 |
| Listenai | Listenai develops AI processors and software platforms for intelligent edge devices. | Artificial intelligence | Hefei, China | Series B | $73.7M | 2026-07-10 | $73.7M | Oriza Holdings, FutureX Capital, Cedarlake Capital | 11 to 50 | 2020 |
| TuringQ | TuringQ researches quantum information and manufactures optical quantum chips and computers. | Artificial intelligence | Shanghai, China | Series B | $13.9M | 2026-04-27 | $45.3M | Legend Capital, Lenovo Capital and Incubator Group (LCIG), Oriza Holdings +2 | 101 to 250 | 2021 |
| Neurodome | Neurodome manufactures non-invasive deep brain nerve modulation technology and products. | Biotech | Xian Shi, China | Series A | $14.5M | 2026-03-12 | $14.5M | Shunwei Capital, Frees Fund, Oriza Holdings +2 | 11 to 50 | 2019 |
| Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village, United States | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| Gazer | Gazer develops semiconductor equipment and sensors. | Hardware | Putuo, China | Series B | $14.1M | 2025-12-08 | $14.1M | Oriza Holdings, Suzhou International Development Venture Capital, SND Ventures Group +1 | 2021 | |
| Skysys | Skysys provides data acquisition and analysis services for drones. | Artificial intelligence | Suzhou, China | Series B | $13.9M | 2025-06-23 | $39.3M | Oriza Holdings, Ivy Capital, CM Venture Capital | 11 to 50 | 2017 |
| EAVISION | EAVISION researches and develops drones for applications including agriculture. | Artificial intelligence | Suzhou, China | Series D | $11.8M | 2025-04-01 | $67.4M | Temasek, Oriza Holdings, Continental Grain Company | 101 to 250 | 2016 |
| CureGenetics | CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. | Biotech | Suzhou, China | Series B | $9.0M | 2024-03-28 | Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 | 51 to 100 | 2016 | |
| Wattsine | Wattsine develops and manufactures solid-state radio frequency generator systems. | Energy | Chengdu, China | Series B | $28.0M | 2023-12-20 | Yonghua Capital, Oriza Holdings, GP Capital +2 | 51 to 100 | 2015 | |
| Atom Bioscience & Pharmaceutical | Atom Bioscience is a clinical-stage biotechnology company. | Biotech | Suzhou, China | Series D | $82.1M | 2023-10-16 | Fortune Venture Capital, Oriza Holdings, Kaitai Capital +1 | 11 to 50 | 2012 | |
| VirtAI Tech | VirtAI Tech provides AI accelerator virtualization and resource management software for data centers. | Artificial intelligence | Haidian, China | Series B | $10.0M | 2021-07-12 | Hillhouse Investment, Gobi Partners, Oriza Holdings +1 | 11 to 50 | 2019 | |
| SequoiaDB | SequoiaDB sells distributed database software. | Fintech | Guangzhou, China | Series D | $35.0M | 2020-10-13 | Qiming Venture Partners, DCM Ventures, CICC +2 | 51 to 100 | 2012 | |
| CloudWalk Technology | CloudWalk Technology provides facial recognition services for finance, public security, and aviation sectors. | Artificial intelligence | Beijing, China | Series C | $253.7M | 2020-05-14 | Shunwei Capital, Puhua Capital, Oriza Holdings +1 | 1,001 to 5,000 | 2015 | |
| Yingtu | Yingtu is an online platform where people share experiences about goods. | Software | Yuhang, China | Series A | $1.5M | 2017-08-24 | Oriza Holdings | 11 to 50 | 2016 |
Table 1. Oriza Holdings portfolio companies: the 15 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 41.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village, United States | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| 2 | Listenai | Listenai develops AI processors and software platforms for intelligent edge devices. | Artificial intelligence | Hefei, China | Series B | $73.7M | 2026-07-10 | $73.7M | Oriza Holdings, FutureX Capital, Cedarlake Capital | 11 to 50 | 2020 |
| 3 | Mogulinker Technology | Mogulinker Technology supplies SaaS software for the post-industrial equipment market. | Artificial intelligence | Shenzhen, China | Series C | $14.9M | 2026-09-03 | $32.4M | GGV Capital, Yinxinggu Capital, Oriza Holdings +1 | 51 to 100 | 2016 |
| 4 | Neurodome | Neurodome manufactures non-invasive deep brain nerve modulation technology and products. | Biotech | Xian Shi, China | Series A | $14.5M | 2026-03-12 | $14.5M | Shunwei Capital, Frees Fund, Oriza Holdings +2 | 11 to 50 | 2019 |
| 5 | Gazer | Gazer develops semiconductor equipment and sensors. | Hardware | Putuo, China | Series B | $14.1M | 2025-12-08 | $14.1M | Oriza Holdings, Suzhou International Development Venture Capital, SND Ventures Group +1 | 2021 | |
| 6 | TuringQ | TuringQ researches quantum information and manufactures optical quantum chips and computers. | Artificial intelligence | Shanghai, China | Series B | $13.9M | 2026-04-27 | $45.3M | Legend Capital, Lenovo Capital and Incubator Group (LCIG), Oriza Holdings +2 | 101 to 250 | 2021 |
Table 2. Oriza Holdings portfolio companies: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 3 | 7% | ||
| 2 | Oriental Fortune Capital | Venture capital firm | Shenzhen, China | 3 | 7% | ||
| 3 | Hua Capital | Private equity firm | Beijing, China | 3 | 7% | ||
| 4 | Legend Capital | Venture capital firm | Beijing, China | 2 | 5% | 2 | TuringQ, Angitia Biopharmaceuticals |
| 5 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 2 | 5% | 1 | TuringQ |
| 6 | Wuxi Capital | Angel group | Wuxi Shi, China | 2 | 5% | 2 | Muchuang, TuringQ |
| 7 | Shunwei Capital | Venture capital firm | Beijing, China | 2 | 5% | 1 | Neurodome |
| 8 | Puhua Capital | Venture capital firm | Hangzhou, China | 2 | 5% | ||
| 9 | Suzhou International Development Venture Capital | Venture capital firm | Suzhou, China | 2 | 5% | 1 | Gazer |
| 10 | GSR Ventures | Venture capital firm | Menlo Park, United States | 2 | 5% | ||
| 11 | Suzhou Industrial Park Science and Technology Fund | Venture capital firm | Suzhou, China | 2 | 5% | ||
| 12 | China Merchants Venture Capital | Venture capital firm | Shenzhen, China | 2 | 5% | ||
| 13 | Morningside | Private equity firm | Newton, United States | 1 | 2% | 1 | Angitia Biopharmaceuticals |
| 14 | OrbiMed | Private equity firm | New York, United States | 1 | 2% | 1 | Angitia Biopharmaceuticals |
| 15 | GGV Capital | Venture capital firm | Menlo Park, United States | 1 | 2% | 1 | Mogulinker Technology |
Table 3. Oriza Holdings portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 23 | 56% | $258.1M |
| Hardware | 14 | 34% | $282.1M |
| Artificial intelligence | 13 | 32% | $258.1M |
| Health care | 7 | 17% | $444.1M |
| Biotech | 5 | 12% | $439.3M |
| Energy | 3 | 7% | $32.4M |
| Commerce | 2 | 5% | |
| Fintech | 1 | 2% |
Table 4. Oriza Holdings portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Oriza Holdings portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| China | 40 | 98% |
| United States | 1 | 2% |
Table 6. Oriza Holdings portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Oriza Holdings portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 14% | $14.9M |
| August 2026 | 1 | 14% | |
| July 2026 | 1 | 14% | $73.7M |
| April 2026 | 1 | 14% | $13.9M |
| March 2026 | 1 | 14% | $14.5M |
| February 2026 | 1 | 14% | $130.0M |
| December 2025 | 1 | 14% | $14.1M |
Table 8. Oriza Holdings portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 6 | 15% | $247.1M |
| 2025 | 4 | 10% | $53.7M |
| 2024 | 5 | 12% | $50.8M |
| 2023 | 7 | 17% | $118.3M |
| 2022 | 3 | 7% | |
| 2021 | 4 | 10% | $53.3M |
Table 9. Oriza Holdings portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 6 | 15% |
| 2015 to 2019 | 23 | 56% |
| 2010 to 2014 | 9 | 22% |
| Before 2010 | 3 | 7% |
Table 10. Oriza Holdings portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 11 to 50 | 19 | 50% |
| 51 to 100 | 10 | 26% |
| 101 to 250 | 4 | 11% |
| 251 to 500 | 1 | 3% |
| 501 to 1,000 | 1 | 3% |
| 1,001 to 5,000 | 3 | 8% |
Table 11. Oriza Holdings portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Oriza Holdings is recorded as one of its investors. On 16 November 2026 that is 41 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 15 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 41 rows: 12 have no round amount, 0 no city and 16 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Oriza Holdings portfolio companies are on the list?
- 41, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 41 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.